Anti-inflammatory drugs targeting inflammatory bowel disease (IBD) have attracted
considerable attention but still face low therapeutic outcomes and frequent side effects …

Orally targeted strategy of anti-inflammatory agents has attracted tremendous attention for
reducing highly health-care costs and enhancing the intervention efficiency of ulcerative …

The oral delivery strategy of natural anti-oxidant and anti-inflammatory agents has attracted
great attention to improve the effectiveness of ulcerative colitis (UC) treatment. Herein, we …

Dextran sulfate sodium is one of the important members in the field of polysaccharide
biotechnology, which can induce inflammatory bowel disease (IBD) in the gastrointestinal …

As a fat-soluble carotenoid, astaxanthin has excellent antioxidant and anti-inflammation
biological activities, but its poor biocompatibility and low stability limit application of …

Smart delivery systems with stimuli-responsive capability are able to improve the
bioaccessibility through increasing the solubility, physicochemical stability and …

Oral administration of astaxanthin (AST), a potent antioxidant, is limited owing to its low
solubility, physicochemical stability, and bioavailability. This study developed pH-responsive …

A significant gap exists in the demand for safe and effective drugs for inflammatory bowel
disease (IBD), and its associated intestinal fibrosis. As oxidative stress plays a central role in …

The controlled release of antioxidant substances at the intestinal oxidative damage site is
crucial for alleviating intestine-related diseases. Herein, the novel ROS-responsive carrier …

Nanoparticles (NPs) have the capacity to improve the bioactivity and bioavailability of anti-
inflammatory drugs. Here, a green drug nanocarrier based on ovalbumin (OVA) was facilely …